Intervention Protocol

Lexipafant for acute pancreatitis

  1. Xunzhe Yang2,
  2. Xiaoxi Zeng2,
  3. Taixiang Wu1,*

Editorial Group: Cochrane Upper Gastrointestinal and Pancreatic Diseases Group

Published Online: 7 SEP 2011

DOI: 10.1002/14651858.CD009309


How to Cite

Yang X, Zeng X, Wu T. Lexipafant for acute pancreatitis (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD009309. DOI: 10.1002/14651858.CD009309.

Author Information

  1. 1

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese Evidence-Based Medicine Centre, INCLEN Resource and Training Centre, Chengdu, Sichuan, China

  2. 2

    West China Hospital, Sichuan University, Chengdu, Sichuan, China

*Taixiang Wu, Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese Evidence-Based Medicine Centre, INCLEN Resource and Training Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. txwutx@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 7 SEP 2011

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the therapeutic potential of lexipafant: whether it can alter the course of the disease, prevent or treat organ failure, and reduce mortality in acute pancreatitis.